Hospital horizontal and vertical consolidation has a number of pernicious effects. One is described in a Milliman report on cancer care costs. (Milliman Report) The researchers compared costs for non-small cell lung cancer, colorectal cancer and breast cancer patients receiving either adjuvant chemotherapy or metastatic chemotherapy at a physician’s office versus in a hospital outpatient setting. The data source was a commercial claims database for the years 2009 and 2010 and the comparisons were adjusted for various patient characteristics. The lowest difference was for adjuvant therapy for colorectal cancer at a mere 28% more for hospital outpatient treatment and the highest was for metastatic chemotherapy for colorectal cancer, 53% higher. Adjuvant breast cancer therapy and metastatic lung cancer treatment were both around 50% higher in the hospital setting. No treatment was cheaper. Hospital ownership of oncology practices has increased rapidly, with one source predicting it will be 42% by 2015, and the incentive to move treatment to the hospital outpatient setting is obvious. Hospital facility charges are very high and unit costs for drugs are at least twice as high. In most cases, there is no reason why patients cannot be treated in a physician’s office and the much greater cost of hospital outpatient services also usually means higher cost-sharing for the patient. MedPAC has been urging CMS for years to equalize the payments for the same service across settings. Commercial payers seldom have the leverage CMS has in regard to hospitals. This is blatant abuse of market power which just wastes money. While cancer patients make up a small part of the commercial population, they obviously have disproportionate costs, and paying only the physician office rates, regardless of setting, would result in significant savings. If necessary, policymakers should enact legislation or rules to equalize payments and end this unnecessarily expensive effect of the hospital system aggregation of providers.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
More money pouring into young health care companies as Dispatch Health gains $330 million in new capital to deliver high acuity health care in a patient’s home, rather than a...
November 30, 2022
A lot of money is invested in health care startups and growth companies, since health care is 20% of the economy, but the returns aren’t always good. Here is another...
November 1, 2022
HealthJoy delights investors by garnering $60 million in mindless new capital to support its benefits navigation tool. Another sign of too much capital still floating around out there.
November 1, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace